Announcements Trials
Browse Landscape

Phase

Phase 3 23Phase 2 11Phase NA 9Phase 4 6Phase EARLY_PHASE1 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Multiple Myeloma 8Leukemia 6Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Burkitt Lymphoma 3Recurrence 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms, Plasma Cell 2Lymphoma 2Leukemia, T-Cell 2Waldenstrom Macroglobulinemia 1Vomiting 1Uterine Cervical Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Mouth Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Leukemia, Myeloid, Acute 1Fatigue 1Congenital Abnormalities 1Breast Neoplasms 1Breast Carcinoma In Situ 1Brain Neoplasms 1

Interventions

Olanzapine 2netupitant, palosentron drug combination 1netupitant 1ginger extract 1Therapeutics 1Palonosetron 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Vomiting × Dexamethasone × Clear all
NCT03668639 2021-12-14

Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin

Odense University Hospital

Phase 2/3 Unknown
80 enrolled
Gynecologic

Uterine Cervical Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡